The embattled AI data annotation firm Sama is winding down its operations and liquidating its assets, according to a letter to creditors reviewed by TIME.
Why Perrigo Stock Is Back In Focus Perrigo (PRGO) has come back onto investors’ radar after a weak third quarter, fresh 2026 guidance pointing to mid single digit sales contraction, and a reaffirmed quarterly dividend. The new outlook calls for net sales in 2026 to decline between 5.7% and 4.6% year over year, which puts the earnings update front and center for anyone tracking the self care healthcare group. Perrigo’s share price has climbed 23.4% over the past 90 days and 8.9% over the last...
Retailers are ordering cautiously, yet Perrigo's European health brands grew well ahead of their categories and took share.
Perrigo keeps selling assets and offers a 7% yield, but weak growth, leverage, and execution risks cloud the value case. Learn more about PRGO stock here.
Detailed price information for Iqvia Holdings Inc (IQV-N) from The Globe and Mail including charting and trades.
As AI companies warn of the dangers of self-improving AI, a new report offers a rare look at how they’re working to make it a reality.
Perrigo (PRGO) draws takeover buzz as CVC Capital is rumored to explore a deal to merge it with Cooper Consumer Health—plus Stada/CapVest interest.
Perrigo (PRGO) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
This is the newest page. Registered accounts read further back.